跳转至内容
Merck
CN

T3021

替硝唑

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C8H13N3O4S
化学文摘社编号:
分子量:
247.27
UNSPSC Code:
51101500
PubChem Substance ID:
EC Number:
243-014-4
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

SMILES string

CCS(=O)(=O)CCn1c(C)ncc1N(=O)=O

正在寻找类似产品? 访问 产品对比指南

General description

Chemical structure: imidazole

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

C E Nord et al.
Infection, 11(1), 54-60 (1983-01-01)
Tinidazole is a 5-nitroimidazole with selective activity against anaerobic bacteria and protozoa. It is bactericidal at low concentrations and its spectrum covers most anaerobic bacteria and some capnophilic microorganisms. Anaerobic bacteria known to be resistant to tinidazole include anaerobic streptococci
Hyuk Soon Choi et al.
World journal of gastroenterology, 18(19), 2377-2382 (2012-06-02)
To compare the effectiveness of sequential therapy for Helicobacter pylori (H. pylori) infection with that of triple therapy of varying durations. The 460 patients enrolled in this study had H. pylori-associated gastritis or a gastric or duodenal ulcer. After screening
Horatio B Fung et al.
Clinical therapeutics, 27(12), 1859-1884 (2006-03-02)
Tinidazole, a structural analogue of metrondazole, is an antiprotozoal agent that has been widely used in Europe and developing countries for >2 decades with established efficacy and acceptable tolerability. It was recently approved by the US Food and Drug Administration
Arlene C Seña et al.
The Journal of infectious diseases, 206(3), 357-365 (2012-05-23)
Chlamydia trachomatis (CT), Mycoplasma genitalium (MG), and Trichomonas vaginalis (TV) are sexually transmitted infections (STIs) associated with nongonococcal urethritis (NGU). We assessed their predictors and persistence after treatment. We analyzed data from an NGU treatment trial among symptomatic heterosexual men
Alessandro Federico et al.
Gastroenterology, 143(1), 55-61 (2012-04-10)
Helicobacter pylori have become resistant to antimicrobial agents, reducing eradication rates. A 10-day sequential regimen that contains levofloxacin was efficient, safe, and cost saving in eradicating H pylori infection in an area with high prevalence of clarithromycin resistance. We performed

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持